| Dr Geoffery Engel, MD | |
|
136 Biesterfield Rd, Elk Grove Village, IL 60007-3657 | |
| (847) 823-3185 | |
| (847) 823-3318 |
| Full Name | Dr Geoffery Engel |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 52 Years |
| Location | 136 Biesterfield Rd, Elk Grove Village, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124076559 | NPI | - | NPPES |
| 036047476 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 036047476 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwestern Memorial Hospital | Chicago, IL | Hospital |
| Alexian Brothers Medical Center 1 | Elk grove village, IL | Hospital |
| St Alexius Medical Center | Hoffman estates, IL | Hospital |
| Central Dupage Hospital | Winfield, IL | Hospital |
| Palos Community Hospital | Palos heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwestern Medical Faculty Foundation | 4587576814 | 3255 |
| Uropartners Llc | 9436182946 | 118 |
News Archive
Giving supplement such as herbs, vitamins, and other natural health products to children taking Warfarin for congenital heart defects could increase their risk of clots, bleeding, and other complications, nurse practitioner Mary Bauman and Dr. Patti Massicotte told the 2008 Canadian Cardiovascular Congress, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Two recently published studies by a research team at University Hospitals Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and "is a disease in urgent need of new drug therapies," write the study's authors.
DASH FOR DAD, the premier prostate cancer race series in the U.S., is a heartfelt tight-knit community event that brings together athletes, cancer survivors, physicians, caregivers, family members and friends. Proceeds from each 10K race are used to provide free prostate cancer testing for men in the local community of the event.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
An analysis published June 25th in the open-access journal PLoS Neglected Tropical Diseases highlights that diseases very similar to those plaguing Africa, Asia, and Latin America are also occurring frequently among the poorest people in the United States, especially women and children. These diseases - the "neglected infections of poverty" - are caused by chronic and debilitating parasitic, bacterial, and congenital infections.
› Verified 5 days ago
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
Giving supplement such as herbs, vitamins, and other natural health products to children taking Warfarin for congenital heart defects could increase their risk of clots, bleeding, and other complications, nurse practitioner Mary Bauman and Dr. Patti Massicotte told the 2008 Canadian Cardiovascular Congress, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Two recently published studies by a research team at University Hospitals Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and "is a disease in urgent need of new drug therapies," write the study's authors.
DASH FOR DAD, the premier prostate cancer race series in the U.S., is a heartfelt tight-knit community event that brings together athletes, cancer survivors, physicians, caregivers, family members and friends. Proceeds from each 10K race are used to provide free prostate cancer testing for men in the local community of the event.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
An analysis published June 25th in the open-access journal PLoS Neglected Tropical Diseases highlights that diseases very similar to those plaguing Africa, Asia, and Latin America are also occurring frequently among the poorest people in the United States, especially women and children. These diseases - the "neglected infections of poverty" - are caused by chronic and debilitating parasitic, bacterial, and congenital infections.
› Verified 5 days ago
| Entity Name | United Shockwave Services Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497132377 PECOS PAC ID: 8729984448 Enrollment ID: O20031211000738 |
News Archive
Giving supplement such as herbs, vitamins, and other natural health products to children taking Warfarin for congenital heart defects could increase their risk of clots, bleeding, and other complications, nurse practitioner Mary Bauman and Dr. Patti Massicotte told the 2008 Canadian Cardiovascular Congress, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Two recently published studies by a research team at University Hospitals Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and "is a disease in urgent need of new drug therapies," write the study's authors.
DASH FOR DAD, the premier prostate cancer race series in the U.S., is a heartfelt tight-knit community event that brings together athletes, cancer survivors, physicians, caregivers, family members and friends. Proceeds from each 10K race are used to provide free prostate cancer testing for men in the local community of the event.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
An analysis published June 25th in the open-access journal PLoS Neglected Tropical Diseases highlights that diseases very similar to those plaguing Africa, Asia, and Latin America are also occurring frequently among the poorest people in the United States, especially women and children. These diseases - the "neglected infections of poverty" - are caused by chronic and debilitating parasitic, bacterial, and congenital infections.
› Verified 5 days ago
| Entity Name | Uropartners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073567905 PECOS PAC ID: 9436182946 Enrollment ID: O20050915000277 |
News Archive
Giving supplement such as herbs, vitamins, and other natural health products to children taking Warfarin for congenital heart defects could increase their risk of clots, bleeding, and other complications, nurse practitioner Mary Bauman and Dr. Patti Massicotte told the 2008 Canadian Cardiovascular Congress, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Two recently published studies by a research team at University Hospitals Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and "is a disease in urgent need of new drug therapies," write the study's authors.
DASH FOR DAD, the premier prostate cancer race series in the U.S., is a heartfelt tight-knit community event that brings together athletes, cancer survivors, physicians, caregivers, family members and friends. Proceeds from each 10K race are used to provide free prostate cancer testing for men in the local community of the event.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
An analysis published June 25th in the open-access journal PLoS Neglected Tropical Diseases highlights that diseases very similar to those plaguing Africa, Asia, and Latin America are also occurring frequently among the poorest people in the United States, especially women and children. These diseases - the "neglected infections of poverty" - are caused by chronic and debilitating parasitic, bacterial, and congenital infections.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Geoffery Engel, MD 1660 Feehanville Dr Ste 200, Mount Prospect, IL 60056-6036 Ph: (847) 823-3185 | Dr Geoffery Engel, MD 136 Biesterfield Rd, Elk Grove Village, IL 60007-3657 Ph: (847) 823-3185 |
News Archive
Giving supplement such as herbs, vitamins, and other natural health products to children taking Warfarin for congenital heart defects could increase their risk of clots, bleeding, and other complications, nurse practitioner Mary Bauman and Dr. Patti Massicotte told the 2008 Canadian Cardiovascular Congress, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Two recently published studies by a research team at University Hospitals Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and "is a disease in urgent need of new drug therapies," write the study's authors.
DASH FOR DAD, the premier prostate cancer race series in the U.S., is a heartfelt tight-knit community event that brings together athletes, cancer survivors, physicians, caregivers, family members and friends. Proceeds from each 10K race are used to provide free prostate cancer testing for men in the local community of the event.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
An analysis published June 25th in the open-access journal PLoS Neglected Tropical Diseases highlights that diseases very similar to those plaguing Africa, Asia, and Latin America are also occurring frequently among the poorest people in the United States, especially women and children. These diseases - the "neglected infections of poverty" - are caused by chronic and debilitating parasitic, bacterial, and congenital infections.
› Verified 5 days ago
George Schuster, MD Urology Medicare: Medicare Enrolled Practice Location: 136 Biesterfield Rd, Elk Grove Village, IL 60007 Phone: 847-823-3185 Fax: 847-823-3318 | |
Dr. Eric Dybal, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 800 Biesterfield Rd, Suite 303, Elk Grove Village, IL 60007 Phone: 847-593-0404 Fax: 847-593-1509 | |
Eli Kasimir Michaels, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 136 Biesterfield Rd, Elk Grove Village, IL 60007 Phone: 847-823-3185 Fax: 847-823-3318 | |
Dr. Daniel Garvey, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 303, Elk Grove Village, IL 60007 Phone: 847-593-0404 Fax: 847-593-1509 |